WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Stock Ownership - Who owns Oramed Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oramed Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua HexterCOO CBO2026-07-0250,000$3.69
$184.50kBuy
Avraham GabayChief Financial Officer2026-07-0173,360$4.51
$330.71kSell
Joshua HexterCOO CBO2026-07-01137,000$4.46
$611.43kSell
Miriam KidronChief Scientific Officer2026-03-30435,084$3.31
$1.44MSell
Nadav KidronPresident and CEO2026-03-3044,818$3.31
$148.35kSell

1 of 1

ORMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORMP insiders and whales buy or sell their stock.

ORMP Shareholders

What type of owners hold Oramed Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Zeev Bronfeld15.84%6,589,767$31.37MInsider
Nadav Kidron8.53%3,548,243$16.89MInsider
Regals Capital Management LP6.35%2,640,460$12.57MInsider
Benjamin Shapiro4.86%2,023,220$9.63MInsider
David Mark Slager3.16%1,316,328$6.27MInsider
Gao Xiaoming2.78%1,155,367$5.50MInsider
Miriam Kidron2.72%1,133,138$5.39MInsider
Joshua Hexter2.58%1,073,384$5.11MInsider
Avraham Gabay1.61%671,785$3.20MInsider
Leonard Sank1.51%629,323$3.00MInsider

1 of 3

ORMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORMP0.04%53.95%Net SellingNet Selling
ACOG0.05%33.69%Net BuyingNet Buying
NMRA0.04%87.12%Net BuyingNet Selling
VYGR0.06%48.15%Net Selling
DTIL0.06%99.94%Net Selling
View Top Biotech Stocks

Oramed Pharmaceuticals Stock Ownership FAQ

Who owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals (NASDAQ: ORMP) is owned by 0.04% institutional shareholders, 53.95% Oramed Pharmaceuticals insiders, and 46.01% retail investors. Zeev Bronfeld is the largest individual Oramed Pharmaceuticals shareholder, owning 6.59M shares representing 15.84% of the company. Zeev Bronfeld's Oramed Pharmaceuticals shares are currently valued at $30.71M.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.